Profile data is unavailable for this security.
About the company
Zhejiang Gongdong Medical Technology Co Ltd is a China-based company principally engaged in the research and development, production and sales of disposable medical consumables. The Company's main products cover vacuum blood collection systems, laboratory testing consumables, body fluid collection consumables, medical care consumables and pharmaceutical packaging materials. Its products include disposable vacuum blood collection tubes, petri dishes, culture plates, cuvettes, pipette tips, disposable sterile sampling swabs, dispensers, dressing containers and others. The Company's products are applied in clinical diagnosis and nursing, scientific research and testing, pharmaceutical packaging and other fields. The Company distributes its products in the domestic market and to overseas markets, including many countries in North America, Asia, South America, Africa and Europe.
- Revenue in CNY (TTM)1.02bn
- Net income in CNY125.32m
- Incorporated2019
- Employees1.67k
- LocationZhejiang Gongdong Medical Technology Co LtdNo. 10Beiyuan Avenue, Huangyan DistrictTAIZHOU 318020ChinaCHN
- Phone+86 57 684081101
- Fax+86 57 684050789
- Websitehttps://en.gongdong.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Getein Biotech Inc | 1.31bn | 244.26m | 3.91bn | 2.14k | 16.01 | 1.48 | -- | 2.99 | 0.4816 | 0.4816 | 2.58 | 5.22 | 0.3502 | 1.61 | 2.77 | 611,337.70 | 6.63 | 13.25 | 9.24 | 18.45 | 66.13 | 65.57 | 18.92 | 28.13 | 1.97 | -- | 0.1857 | 29.88 | -24.85 | 14.81 | -43.92 | 2.31 | 18.44 | 6.00 |
Hangzhou Ags Medtech Co Ltd | 529.86m | 235.79m | 3.95bn | 592.00 | 16.80 | 1.76 | -- | 7.46 | 2.91 | 2.91 | 6.54 | 27.80 | 0.3775 | 3.36 | 13.43 | 895,039.90 | 16.80 | -- | 17.73 | -- | 70.24 | -- | 44.50 | -- | 24.45 | -- | 0.0054 | -- | 37.09 | -- | 49.87 | -- | -- | -- |
SWS Hemodialysis Care Co Ltd | 659.16m | 154.15m | 4.06bn | 881.00 | 26.32 | 2.36 | -- | 6.15 | 0.7148 | 0.7148 | 3.06 | 7.97 | 0.3351 | 2.11 | 5.56 | 748,197.70 | 7.71 | -- | 8.68 | -- | 50.81 | -- | 23.00 | -- | 15.96 | -- | 0.0089 | -- | 80.65 | -- | 228.34 | -- | -- | -- |
Jiangsu Bioperfectus Technologies Co Ltd | 400.25m | -314.32m | 4.10bn | 684.00 | -- | 1.19 | -- | 10.23 | -5.36 | -5.36 | 6.83 | 58.77 | 0.0915 | 0.8592 | 1.57 | 585,153.50 | -7.19 | 25.41 | -8.36 | 31.26 | 63.20 | 63.37 | -78.53 | 32.86 | 6.05 | -- | 0.086 | 30.54 | -92.72 | 11.81 | -120.45 | -- | 2.43 | -- |
Shanghai Sanyou Medical Co Ltd | 385.98m | 58.83m | 4.19bn | 466.00 | 73.98 | 2.19 | -- | 10.86 | 0.228 | 0.228 | 1.53 | 7.71 | 0.1699 | 0.5891 | 2.20 | 828,288.80 | 3.29 | 9.42 | 3.86 | 10.85 | 71.52 | 87.15 | 19.34 | 29.78 | 3.35 | -- | 0.0291 | 16.21 | -29.08 | 15.67 | -49.91 | 8.99 | -15.60 | -- |
Assure Tech Hangzhou Co Ltd | 511.29m | 160.91m | 4.27bn | 791.00 | 26.54 | 0.8245 | -- | 8.35 | 1.27 | 1.27 | 4.02 | 40.75 | 0.0799 | 1.52 | 2.67 | 646,379.60 | 2.51 | 31.83 | 2.94 | 38.97 | 38.56 | 65.82 | 31.47 | 47.86 | 8.26 | -- | 0.0166 | 16.05 | -91.84 | 25.18 | -95.35 | 33.51 | 78.77 | -- |
Qingdao NovelBeam Technology Co Ltd | 439.81m | 135.69m | 4.40bn | 797.00 | 32.31 | 3.30 | -- | 10.00 | 1.12 | 1.12 | 3.62 | 10.95 | 0.3138 | 1.08 | 4.50 | 551,832.80 | 9.45 | 14.67 | 10.07 | 16.63 | 62.54 | 62.32 | 30.11 | 34.15 | 11.88 | -- | 0.0039 | 33.55 | -1.31 | 18.58 | -20.19 | 21.71 | 10.45 | -- |
Zhejiang Gongdong Medical Techno Co Ltd | 1.02bn | 125.32m | 4.42bn | 1.67k | 35.21 | 2.62 | -- | 4.33 | 1.11 | 1.11 | 9.07 | 14.98 | 0.5447 | 6.00 | 4.59 | 609,805.40 | 6.69 | 16.35 | 7.46 | 19.26 | 31.13 | 41.19 | 12.28 | 21.62 | 3.85 | -- | 0.0201 | 38.99 | -33.61 | 15.11 | -66.53 | 5.14 | 27.71 | -- |
Innovita Biological Technology Co Ltd | 625.12m | 266.22m | 4.93bn | 404.00 | 18.53 | 2.48 | -- | 7.89 | 1.96 | 1.96 | 4.59 | 14.62 | 0.3093 | 1.67 | 6.23 | 1,547,324.00 | 13.17 | -- | 14.20 | -- | 80.99 | -- | 42.59 | -- | 10.66 | -- | 0.0015 | -- | 7.03 | -- | 15.44 | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
CIB Fund Management Co., Ltd.as of 31 Dec 2023 | 1.11m | 3.94% |
ICBC Credit Suisse Asset Management Co., Ltd.as of 31 Dec 2023 | 868.20k | 3.08% |
Golden Trust Sinopac Fund Management Co., Ltd.as of 31 Dec 2023 | 844.53k | 2.99% |
Essence Fund Co., Ltd.as of 31 Dec 2023 | 473.67k | 1.68% |
Taikang Asset Management Co. Ltd.as of 30 Sep 2022 | 472.40k | 1.67% |
GF Fund Management Co., Ltd.as of 31 Dec 2023 | 418.83k | 1.48% |
Bosera Asset Management Co., Ltd.as of 31 Dec 2023 | 374.70k | 1.33% |
Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 337.90k | 1.20% |
Zhong Ou Asset Management Co., Ltdas of 31 Dec 2023 | 303.30k | 1.07% |
Rongtong Fund Management Co., Ltd.as of 31 Dec 2023 | 296.80k | 1.05% |